Onco-Innovations Limited (NEO:ONCO)
Canada flag Canada · Delayed Price · Currency is CAD
1.550
+0.060 (4.03%)
Jun 6, 2025, 4:00 PM EDT

Onco-Innovations Company Description

Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

Its lead product candidate is ONC010, a novel inhibitor of the deoxyribonucleic acid repair enzyme polynucleotide kinase 3′-phosphatase in a nanoparticle formulation based on the drug delivery technology.

The company is headquartered in Calgary, Canada.

Onco-Innovations Limited
Country Canada
Industry Biological Products, Except Diagnostic Substances
Employees 1
CEO Thomas O’Shaughnessy

Contact Details

Address:
1309 - 7th Street SW
Calgary, British Columbia T2R 1A5
Canada
Website oncoinnovations.com

Stock Details

Ticker Symbol ONCO
Exchange Cboe Canada
Fiscal Year May - April
Reporting Currency CAD
SIC Code 2836

Key Executives

Name Position
Thomas O’Shaughnessy Chief Executive Officer
Nico Mah Chief Financial Officer